sphingosine-1-phosphate-3 antagonists (Allergan)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namesphingosine-1-phosphate-3 antagonists (Allergan)
Drug Alias Namesphingosine-1-phosphate-3 antagonists (Actavis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine 1-phosphate receptor 3 inhibitors
TargetsSphingosine 1-phosphate receptor 3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAllergan Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan PlcAllergan Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A